Northwire Canada EditionWednesday, July 22, 2026
Northwire
CTV 0.110 −4.3% III 7.58 +5.3% NAM 0.240 −2.0% MOG 0.540 +8.0% LUG 79.10 +2.9% TWR 0.165 +3.1% LALI 0.050 +0.0% NFG 2.02 +3.1% APMI 0.145 +0.0% CDE 21.58 +8.3% NVLH 0.075 −11.8% PHNM 0.345 +4.5% AEC 6.71 +11.5% IAU 1.90 +7.3% LOD 0.295 +0.0% FVL 0.990 +8.8% CTV 0.110 −4.3% III 7.58 +5.3% NAM 0.240 −2.0% MOG 0.540 +8.0% LUG 79.10 +2.9% TWR 0.165 +3.1% LALI 0.050 +0.0% NFG 2.02 +3.1% APMI 0.145 +0.0% CDE 21.58 +8.3% NVLH 0.075 −11.8% PHNM 0.345 +4.5% AEC 6.71 +11.5% IAU 1.90 +7.3% LOD 0.295 +0.0% FVL 0.990 +8.8%
Other

PyroGenesis Announces Third Quarter 2025 Results

PYR · Price

Executive Summary

  • PyroGenesis reported Q3 2025 revenue of $3.25 M, an 18.7% decline year‑over‑year, and a net loss of $2.25 M.
  • The company disclosed a $1.2 M cement‑industry contract, progress on the fumed silica reactor (3× surface‑area increase), and continued work with Constellium on plasma torches for aluminum remelting.
  • Post‑quarter financing included two non‑brokered private placements raising approximately $5.0 M in gross proceeds and a warrant repricing to $0.63 per share.

Key Details

  • Financial Highlights (Q3 2025)
  • Revenue: $3,249,540 (down $753,149 YoY).
  • Gross margin: 24% (vs 42% in Q3 2024).
  • Net loss: $2.25 M; Modified EBITDA loss: $1.89 M.
  • Backlog of signed/awarded contracts: $51.6 M (81% USD).

  • Operating Highlights

  • Cement contract: $1.2 M for plasma torch system (Sept 2025).
  • Fumed silica reactor pilot plant: 3× surface‑area increase to 136 m²/g; carbon impurity reduced to 0%.
  • Constellium partnership: Phase 2 industrial implementation of plasma torches in aluminum remelting furnaces (contract announced Aug 5 2025).
  • Waste processing contract: $600,000 with major environmental services firm (July 2025).
  • Tata Steel coke‑oven gas valorisation project: $9.3 M completed (July 2025).

  • Financing Activity

  • Private placement – Unit Group 1: 6,666,665 units @ $0.63/unit → $4.20 M gross; each unit = 1 common share + 1 warrant (exercise $0.28, 48‑month term).
  • Private placement – Unit Group 2: 4,000,000 units @ $0.20/unit → ~$0.80 M gross; warrants exercise $0.40, 24‑month term.
  • First tranche closed (Oct 16 2025): 5,555,556 units sold to CEO for ≈$3.50 M.
  • Second tranche closed (Oct 29 2025): 4,110,000 units sold for ≈$822 k.
  • Warrant repricing (Oct 17 2025): 1,581,250 warrants re‑priced to $0.63/share, expiry extended to July 17 2026 with acceleration clause if TSX price > $0.80 for three consecutive days.

  • Liquidity

  • Cash on hand as of Sept 30 2025: $0.1 M; net working capital deficit $15.3 M.
  • Term loan balance: $0.3 M (down $0.05 M since Dec 2024).

  • Outlook

  • No specific revenue or earnings guidance for 2025 provided.
  • Emphasis on advancing plasma‑torch projects in aluminum, cement, and waste processing; continued cost‑optimization targeting $3–$5 M savings in 2025.

Notable Quotes

“The $1.2 million contract secured in September with a cement industry customer is an example of new sectors we view as emerging focal points for plasma innovation.” – P. Peter Pascali, President & CEO
“For Q4, buoyed by our recent financing, we are focused on delivering a strong finish to the year and setting the stage for 2026.” – P. Peter Pascali


Materiality Assessment: Material – Negative (significant revenue decline, net loss, and financing activities that materially affect investors).

Read the original news release →

More from PYROGENESIS INC.